Abstract:

Cerebral Palsy (CP) is a disabling condition that affects a child’s life and his/her family irreversibly. It is usually
a non-progressive condition but improvement over time is rarely seen. The condition can be due to prenatal
hypoxia, metabolic, genetic, infectious, traumatic or other causes. It is therefore a heterogeneous group that
results in functional motor disability associated with different degrees of cognitive abnormalities. There are no
treatments that can cure or even improve CP and the best available approach aims at functional, social and nutritional
supportive care and counseling. In this paper, we report 17 sequential patients with CP treated with intrathecal administration of Bone Marrow Mononuclear Cells (BMMC). All patients had an uneventful post-injection course with 73%
of the evaluable patients treated having a good response using the Gross Motor Function Classification System
(GMFCS). The average improvement was 1.3 levels on the GMFCS with cognitive improvements as well.

Full Text:

ijsc-09-090